Susquehanna International Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Susquehanna International Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,601,900	Closed	-$277M	–	10865
2015 Q1	$277M	Buy	1,601,900 +347,300	+28%	+$51M	0.13%	132
2014 Q4	$144M	Buy	1,254,600 +703,300	+128%	+$85.2M	0.06%	297
2014 Q3	$86.1M	Buy	551,300 +166,100	+43%	+$24.1M	0.03%	472
2014 Q2	$47.5M	Buy	385,200 +271,800	+240%	+$30M	0.02%	729
2014 Q1	$11.7M	Sell	113,400 -193,700	-63%	-$19.8M	0.01%	1832
2013 Q4	$27.6M	Buy	307,100 +31,600	+11%	+$2.52M	0.01%	1076
2013 Q3	$18.4M	Buy	275,500 +238,100	+637%	+$16.4M	0.01%	1282
2013 Q2	$2.47M	Buy	+37,400	New	+$2.14M	﹤0.01%	3588

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Susquehanna International Group's SLXP Position: Q2 2015 in Review

Susquehanna International Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 41,580 shares — an estimated $7.19M sold.

Susquehanna International Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $57.7M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Susquehanna International Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Susquehanna International Group sold 41,580 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $7.19M.
Susquehanna International Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Susquehanna International Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $57.7M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.